Individuals with increased inflammatory response to ozone demonstrate muted signaling of immune cell trafficking pathways

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Fry, Rebecca C ^a   Rager, Julia E ^a   Zhou, Haibo ^b,c   Zou, Baiming ^c   Brickey, June W ^b   Ting, Jenny ^b   Lay, John C ^b,d   Peden, David B ^b,d   Alexis, Neil E ^b,d  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Air pollution; Environment; Gene expression; Human sputum; Immune response; Innate immunity; Ozone; Systems biology

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 8; OZONE; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ADULT; ARTICLE; CELL MIGRATION; CELL SURFACE; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MALE; MICROARRAY ANALYSIS; NEUTROPHIL; OXIDATIVE STRESS; PHAGOCYTOSIS; PHENOTYPE; PREDICTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPUTUM; AIR POLLUTANT; ASTHMA; CELL MOTION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; EXPOSURE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; LUNG; MACROPHAGE; METABOLISM; RESPIRATORY BURST; SYSTEMS BIOLOGY; TIME;

ADULT; AIR POLLUTANTS; ASTHMA; BIOLOGICAL MARKERS; CELL MOVEMENT; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; INHALATION EXPOSURE; LUNG; MACROPHAGES; MALE; NEUTROPHILS; OZONE; PHAGOCYTOSIS; PHENOTYPE; RESPIRATORY BURST; SIGNAL TRANSDUCTION; SPUTUM; SYSTEMS BIOLOGY; TIME FACTORS; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84866863745     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-89     Document Type: Article

References (25)

1. Babin SM, Burkom HS, Holtry RS, Tabernero NR, Stokes LD, Davies-Cole JO, DeHaan K, Lee DH. Pediatric patient asthma-related emergency department visits and admissions in Washington, DC, from 2001-2004, and associations with air quality, socio-economic status and age group. Environ Health 2007, 6:9. 10.1186/1476-069X-6-9, 1845147, 17376237.
2. Fauroux B, Sampil M, Quénel P, Lemoullec Y. Ozone: a trigger for hospital pediatric asthma emergency room visits. Pediatr Pulmonol 2000, 30:41-46. 10.1002/1099-0496(200007)30:1<41::AID-PPUL7>3.0.CO;2-4, 10862161.
3. Hiltermann TJ, Peters EA, Alberts B, Kwikkers K, Borggreven PA, Hiemstra PS, Dijkman JH, van Bree LA, Stolk J. Ozone-induced airway hyperresponsiveness in patients with asthma: role of neutrophil-derived serine proteinases. Free Radic Biol Med 1998, 24:952-958. 10.1016/S0891-5849(97)00381-X, 9607605.
4. Kehrl HR, Peden DB, Ball B, Folinsbee LJ, Horstman D. Increased specific airway reactivity of persons with mild allergic asthma after 7.6 hours of exposure to 0.16 ppm ozone. J Allergy Clin Immunol 1999, 104:1198-1204. 10.1016/S0091-6749(99)70013-8, 10589001.
5. Molfino NA, Wright SC, Katz I, Tarlo S, Silverman F, McClean PA, Szalai JP, Raizenne M, Slutsky AS, Zamel N. Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects. Lancet 1991, 338:199-203. 10.1016/0140-6736(91)90346-Q, 1676776.
6. EPA Air quality criteria for ozone and related photochemical oxidants (2006 final) 2006, US: Environmental Protection Agency, Book Air quality criteria for ozone and related photochemical oxidants (2006 final). (Editor ed.^eds.), vol. I. City, EPA.
7. Schwela D. Air pollution and health in urban areas. Rev Environ Health 2000, 15:13-42.
8. Alexis NE, Lay JC, Hazucha M, Harris B, Hernandez ML, Bromberg PA, Kehrl H, Diaz-Sanchez D, Kim C, Devlin RB, Peden DB. Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans. Inhal Toxicol 2010, 22:593-600. 10.3109/08958371003596587, 3162473, 20384440.
9. Kim CS, Alexis NE, Rappold AG, Kehrl H, Hazucha MJ, Lay JC, Schmitt MT, Case M, Devlin RB, Peden DB, Diaz-Sanchez D. Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Am J Respir Crit Care Med 2011, 183:1215-1221. 10.1164/rccm.201011-1813OC, 3114053, 21216881.
10. Alexis NE, Zhou H, Lay JC, Harris B, Hernandez ML, Lu TS, Bromberg PA, Diaz-Sanchez D, Devlin RB, Kleeberger SR, Peden DB. The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. J Allergy Clin Immunol 2009, 124:1222-1228. 10.1016/j.jaci.2009.07.036, 3038610, 19796798.
11. Bauer AK, Travis EL, Malhotra SS, Rondini EA, Walker C, Cho HY, Trivedi S, Gladwell W, Reddy S, Kleeberger SR. Identification of novel susceptibility genes in ozone-induced inflammation in mice. Eur Respir J 2009, 36:428-437. 3027140, 20032013.
12. Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, Harris B, Tal-Singer R, Peden DB. Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers. Environ Health Perspect 2008, 116:799-805. 10.1289/ehp.10981, 2430237, 18560537.
13. Lazaar AL, Sweeney LE, MacDonald AJ, Alexis NE, Chen C, Tal-Singer R. SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br J Clin Pharmacol 2011, 72:282-293. 10.1111/j.1365-2125.2011.03968.x, 3162658, 21426372.
14. Holz O, Khalilieh S, Ludwig-Sengpiel A, Watz H, Stryszak P, Soni P, Tsai M, Sadeh J, Magnussen H. SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects. Eur Respir J 2009, 35:564-570.
15. Alexis NE, Hu SC, Zeman K, Alter T, Bennett WD. Induced sputum derives from the central airways: confirmation using a radiolabeled aerosol bolus delivery technique. Am J Respir Crit Care Med 2001, 164:1964-1970.
16. Hu SC, Ben-Jebria A, Ultman JS. Longitudinal distribution of ozone absorption in the lung: effects of respiratory flow. J Appl Physiol 1994, 77:574-583.
17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
18. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979, 74:829-836.
19. Zhang Y, Szustakowski J, Schinke M. Bioinformatics analysis of microarray data. Methods Mol Biol 2009, 573:259-284. 10.1007/978-1-60761-247-6_15, 19763933.
20. Becker RA, Chambers JM, Wilks AR. The new S language 1988, New York: Chapman & Hall.
21. Palmer C, Diehn M, Alizadeh AA, Brown PO. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 2006, 7(115):1-15. 1368968, 16403227.
22. Fry RC, Svensson JP, Valiathan C, Wang E, Hogan BJ, Bhattacharya S, Bugni JM, Whittaker CA, Samson LD. Genomic predictors of interindividual differences in response to DNA damaging agents. Genes Dev 2008, 22:2621-2626. 10.1101/gad.1688508, 2559901, 18805990.
23. McConnell R, Berhane K, Gilliland F, London SJ, Islam T, Gauderman WJ, Avol E, Margolis HG, Peters JM. Asthma in exercising children exposed to ozone: a cohort study. Lancet 2002, 359:386-391. 10.1016/S0140-6736(02)07597-9, 11844508.
24. Alexeeff SE, Litonjua AA, Suh H, Sparrow D, Vokonas PS, Schwartz J. Ozone exposure and lung function: effect modified by obesity and airways hyperresponsiveness in the VA normative aging study. Chest 2007, 132:1890-1897. 10.1378/chest.07-1126, 17925423.
25. Laskin DL, Sunil V, Guo Y, Heck DE, Laskin JD. Increased nitric oxide synthase in the lung after ozone inhalation is associated with activation of NF-kappa B. Environ Health Perspect 1998, 106(Suppl 5):1175-1178. 10.1289/ehp.98106s51175, 1533360, 9788894.